XGX Pharma ApS

  • Active

  • Registration 32289290
  • APS
  • Established 14 July, 2009

Company information
No advertising

Legal form
Anpartsselskab (APS)
Status

Active

Established 14 July, 2009
Address
Frederiksgade 11, st.th
1265 København K
Denmark
Phone: 70276627
Registration number
Registration 32289290

Relations

Past relations
Ultimate beneficial owners (UBOs)
  • Jens-Nikolaj Schøier
    2017-11-01 – 2025-07-21 38% ownership (2024-06-01 – 2025-07-21 ) 39.5% ownership (2022-01-28 – 2022-07-06 ) 43% ownership (2022-07-07 – 2024-05-31 ) 43.12% ownership (2019-11-22 – 2022-01-27 ) 50% ownership (2017-11-01 – 2019-11-21 ) 38% voting rights (2024-06-01 – 2025-07-21 ) 39.5% voting rights (2022-01-28 – 2022-07-06 ) 43% voting rights (2022-07-07 – 2024-05-31 ) 43.12% voting rights (2019-11-22 – 2022-01-27 ) 50% voting rights (2017-11-01 – 2019-11-21 )
  • Mohammad Sohail Asghar
    2009-07-14 – 2016-06-28 38% ownership (2024-06-01 – 2025-07-21 ) 39.5% ownership (2022-01-28 – 2022-07-06 ) 43% ownership (2022-07-07 – 2024-05-31 ) 43.12% ownership (2019-11-22 – 2022-01-27 ) 50% ownership (2009-07-14 – 2016-06-28 ) 38% voting rights (2024-06-01 – 2025-07-21 ) 39.5% voting rights (2022-01-28 – 2022-07-06 ) 43% voting rights (2022-07-07 – 2024-05-31 ) 43.12% voting rights (2019-11-22 – 2022-01-27 ) 50% voting rights (2009-07-14 – 2016-06-28 )
Legal owners
  • Unimedic Pharma AB
    2025-07-21 – 100% ownership (2025-07-21 – ) 100% voting rights (2025-07-21 – )
  • JCNS Holding ApS 10% ownership (2019-11-22 – 2024-05-31 ) 20% ownership (2024-06-01 – 2025-07-21 ) 10% voting rights (2019-11-22 – 2024-05-31 ) 20% voting rights (2024-06-01 – 2025-07-21 )
  • MSA ApS 50% ownership (2016-06-28 – 2019-11-21 ) 33.33% ownership (2019-11-22 – 2025-07-21 ) 50% voting rights (2016-06-28 – 2019-11-21 ) 33.33% voting rights (2019-11-22 – 2025-07-21 )
  • Schøier Holding ApS 50% ownership (2017-12-21 – 2019-11-21 ) 33.33% ownership (2019-11-22 – 2025-07-21 ) 50% voting rights (2017-12-21 – 2019-11-21 ) 33.33% voting rights (2019-11-22 – 2025-07-21 )
  • JCNS Holding ApS 10% ownership (2019-11-22 – 2024-05-31 ) 20% ownership (2024-06-01 – 2025-07-21 ) 10% voting rights (2019-11-22 – 2024-05-31 ) 20% voting rights (2024-06-01 – 2025-07-21 )
  • E CONSULT ApS 5% ownership (2022-01-28 – 2022-05-10 ) 5% voting rights (2022-01-28 – 2022-05-10 )
  • Schøier Holding ApS 50% ownership (2017-12-21 – 2019-11-21 ) 33.33% ownership (2019-11-22 – 2025-07-21 ) 50% voting rights (2017-12-21 – 2019-11-21 ) 33.33% voting rights (2019-11-22 – 2025-07-21 )
  • MSA ApS 50% ownership (2016-06-28 – 2019-11-21 ) 33.33% ownership (2019-11-22 – 2025-07-21 ) 50% voting rights (2016-06-28 – 2019-11-21 ) 33.33% voting rights (2019-11-22 – 2025-07-21 )
  • Jens-Nikolaj Schøier
    2017-11-01 – 2017-12-21 50% ownership (2017-11-01 – 2017-12-21 ) 50% voting rights (2017-11-01 – 2017-12-21 )
  • Chrisyda Management Ltd.
    2016-06-28 – 2017-11-01 50% ownership (2016-06-28 – 2017-11-01 ) 50% voting rights (2016-06-28 – 2017-11-01 )
Directors
Board members
Subsidiaries
  • Frederiksstaden Pharma ApS 100% ownership (2019-11-22 – 2019-12-26 ) 50% ownership (2019-12-27 – 2022-04-26 ) 100% voting rights (2019-11-22 – 2019-12-26 ) 50% voting rights (2019-12-27 – 2022-04-26 )
  • Frederiksstaden Pharma ApS 100% ownership (2019-11-22 – 2019-12-26 ) 50% ownership (2019-12-27 – 2022-04-26 ) 100% voting rights (2019-11-22 – 2019-12-26 ) 50% voting rights (2019-12-27 – 2022-04-26 )

Employees

XGX Pharma ApS has 5.00 full time equivalents (FTEs) and 5.00 employees as of 1 May, 2025.

Financial reports

Revenue
Profit/loss
'000 12-2012 12-2013 12-2014 12-2015 12-2016 12-2017
Currency DKK DKK DKK DKK DKK DKK
Revenue 0 0 0 0 0 0
Raw materials and consumables used 0 0 0 0 0 0
Other external expenses 0 0 0 0 0 0
Gross profit loss 0 0 0 -33 307 104
Employee benefits expense 0 0 0 0 0 0
Wages and salaries 0 0 0 0 0 0
Depreciation amortisation expense and impairment losses of prop 0 0 0 0 0 0
Profit loss from ordinary operating activities 0 0 -5 -35 307 -146
Profit loss from ordinary activities before tax 0 0 -5 -35 280 -189
Other finance expenses 0 0 0 0 0 43
Tax expense 0 0 9 0 9 0
Profit loss 0 0 -14 -35 272 -189